NL7400095A - - Google Patents
Info
- Publication number
- NL7400095A NL7400095A NL7400095A NL7400095A NL7400095A NL 7400095 A NL7400095 A NL 7400095A NL 7400095 A NL7400095 A NL 7400095A NL 7400095 A NL7400095 A NL 7400095A NL 7400095 A NL7400095 A NL 7400095A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB55373*[A GB1457873A (en) | 1973-01-04 | 1973-01-04 | Imidazotriazines |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7400095A true NL7400095A (en) | 1974-07-08 |
Family
ID=9706420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7400095A NL7400095A (en) | 1973-01-04 | 1974-01-04 |
Country Status (19)
Country | Link |
---|---|
US (1) | US3941785A (en) |
JP (1) | JPS4995994A (en) |
AT (1) | AT336029B (en) |
AU (1) | AU474078B2 (en) |
BE (1) | BE809369A (en) |
CA (1) | CA1005057A (en) |
CH (1) | CH618170A5 (en) |
DE (1) | DE2364076A1 (en) |
ES (1) | ES422001A1 (en) |
FI (1) | FI57260C (en) |
FR (1) | FR2213058B1 (en) |
GB (1) | GB1457873A (en) |
IE (1) | IE38681B1 (en) |
IL (1) | IL43872A (en) |
LU (1) | LU69099A1 (en) |
NL (1) | NL7400095A (en) |
NO (1) | NO140301C (en) |
SE (1) | SE408179B (en) |
ZA (1) | ZA739534B (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK109578A (en) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS |
US4107309A (en) * | 1977-05-23 | 1978-08-15 | American Cyanamid Company | Substituted imidazo[1,2-d]-as-triazines |
US4096257A (en) * | 1977-05-23 | 1978-06-20 | American Cyanamid Company | Substituted imidazo [1,2-d]-as-triazines |
US4126444A (en) * | 1977-11-22 | 1978-11-21 | American Cynamid Company | Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof |
US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
DD244681A3 (en) * | 1985-12-02 | 1987-04-15 | Zeiss Jena Veb Carl | DEVICE FOR POSITIONING END OF FLEXIBLE LIGHTING ELEMENTS |
US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
HU230154B1 (en) | 1997-11-12 | 2015-09-28 | Bayer Intellectual Property Gmbh | Process for the preparation of 2-phenyl substituted imidazotriazinones |
DE19827640A1 (en) * | 1998-06-20 | 1999-12-23 | Bayer Ag | New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction |
JP2002523452A (en) | 1998-08-26 | 2002-07-30 | スミスクライン・ビーチャム・コーポレイション | How to treat lung disease |
DK1212089T3 (en) * | 1999-08-21 | 2006-07-24 | Altana Pharma Ag | Synergistic combination of Roflumilast and Salmeterol |
CN1633298A (en) * | 2001-05-09 | 2005-06-29 | 拜尔健康护理股份公司 | Novel use of 2-phenyl-substituted imidazotriazinones |
GB0113344D0 (en) | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
DE10130167A1 (en) * | 2001-06-22 | 2003-01-02 | Bayer Ag | imidazotriazines |
DE10135815A1 (en) | 2001-07-23 | 2003-02-06 | Bayer Ag | Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain |
DE10230604A1 (en) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Heterocyclically substituted imidazotriazines |
DE10230605A1 (en) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Substituted imidazotriazines |
DE10232113A1 (en) | 2002-07-16 | 2004-01-29 | Bayer Ag | Medicinal products containing vardenafil hydrochloride trihydrate |
US7462614B2 (en) * | 2003-04-01 | 2008-12-09 | Smithkline Beecham Corporation | Imidazotriazine compounds |
DE102005001989A1 (en) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenous formulations of PDE inhibitors |
DE102005009240A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with improved pharmacokinetic properties |
DE102005009241A1 (en) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Dosage forms with controlled bioavailability |
WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
RU2435588C2 (en) * | 2005-09-29 | 2011-12-10 | Байер Шеринг Фарма Акциенгезельшафт | Pde inhibitors and their combinations for treatment of urologic disorders |
EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
JP2009513672A (en) | 2005-10-31 | 2009-04-02 | ブレインセルス,インコーポレイティド | GABA receptor-mediated regulation of neurogenesis |
US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
WO2008030651A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2008036678A2 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
EP2167057A1 (en) * | 2007-06-13 | 2010-03-31 | Bayer HealthCare AG | Pde inhibitors for the treatment of hearing impairment |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791025A (en) * | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | HETEROCYCLIC COMPOUNDS |
-
1973
- 1973-01-04 GB GB55373*[A patent/GB1457873A/en not_active Expired
- 1973-12-18 FI FI3900/73A patent/FI57260C/en active
- 1973-12-18 NO NO4843/73A patent/NO140301C/en unknown
- 1973-12-18 ZA ZA739534A patent/ZA739534B/en unknown
- 1973-12-19 AU AU63774/73A patent/AU474078B2/en not_active Expired
- 1973-12-20 IL IL43872A patent/IL43872A/en unknown
- 1973-12-21 DE DE2364076A patent/DE2364076A1/en not_active Withdrawn
- 1973-12-26 US US05/427,558 patent/US3941785A/en not_active Expired - Lifetime
- 1973-12-28 FR FR7346979A patent/FR2213058B1/fr not_active Expired
- 1973-12-28 CA CA189,199A patent/CA1005057A/en not_active Expired
- 1973-12-31 IE IE2345/73A patent/IE38681B1/en unknown
- 1973-12-31 JP JP49004782A patent/JPS4995994A/ja active Pending
-
1974
- 1974-01-02 CH CH9274A patent/CH618170A5/de not_active IP Right Cessation
- 1974-01-02 LU LU69099A patent/LU69099A1/xx unknown
- 1974-01-02 AT AT2374A patent/AT336029B/en not_active IP Right Cessation
- 1974-01-03 SE SE7400062A patent/SE408179B/en unknown
- 1974-01-03 BE BE139496A patent/BE809369A/en unknown
- 1974-01-03 ES ES422001A patent/ES422001A1/en not_active Expired
- 1974-01-04 NL NL7400095A patent/NL7400095A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
LU69099A1 (en) | 1974-04-02 |
CH618170A5 (en) | 1980-07-15 |
AT336029B (en) | 1977-04-12 |
IL43872A0 (en) | 1974-03-14 |
JPS4995994A (en) | 1974-09-11 |
IE38681B1 (en) | 1978-05-10 |
CA1005057A (en) | 1977-02-08 |
ES422001A1 (en) | 1976-08-01 |
ZA739534B (en) | 1974-11-27 |
FI57260C (en) | 1980-07-10 |
FR2213058A1 (en) | 1974-08-02 |
US3941785A (en) | 1976-03-02 |
SE408179B (en) | 1979-05-21 |
DE2364076A1 (en) | 1974-07-18 |
AU6377473A (en) | 1975-06-19 |
FR2213058B1 (en) | 1977-07-01 |
AU474078B2 (en) | 1976-07-15 |
FI57260B (en) | 1980-03-31 |
GB1457873A (en) | 1976-12-08 |
IL43872A (en) | 1979-01-31 |
IE38681L (en) | 1974-07-04 |
NO140301B (en) | 1979-04-30 |
ATA2374A (en) | 1976-08-15 |
NO140301C (en) | 1979-08-08 |
BE809369A (en) | 1974-07-03 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BV | The patent application has lapsed |